Inactive Instrument

News Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Real-time Estimate Cboe BZX Other stock markets 10:14:40 2024-06-10 am EDT			5-day change	1st Jan Change
6.855 ^USD	0.00%		0.00%	0.00%

May. 15	HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating	MT
May. 14	Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating	May. 15	MT
Fennec Pharmaceuticals : Corporate Presentation May 2024	May. 15	PU
Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024	May. 14
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue	May. 14	MT
Fennec Pharmaceuticals Brief: Company Says Has Approximately US$51 Million in Cash, Cash Equivalents, and Investment Securities	May. 14	MT
Fennec Pharmaceuticals Brief: Achieved Q1 2024 Total Net Revenues of US$25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction	May. 14	MT
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	May. 14	GL
Fennec Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024	May. 07	GL
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	Apr. 23	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	Apr. 19	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	Apr. 17	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	Apr. 05	MT
HC Wainwright Raises Fennec Pharmaceuticals Price Target to $18 From $17, Maintains Buy Rating	Apr. 04	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	Apr. 03	MT
Fennec Pharmaceuticals : Corporate Presentation March 2024	Mar. 30	PU
Wedbush on Fennec's Q4	Mar. 21	MT
Transcript : Fennec Pharmaceuticals Inc., 2023 Earnings Call, Mar 21, 2024	Mar. 21
Fennec Pharmaceuticals up 3.2% in US Premarket, Reports Narrower Q4 Loss of $0.10 Per Share	Mar. 21	MT
Fennec Pharmaceuticals Brief: Cited Pro forma fourth quarter cash in excess of US$55 million	Mar. 21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Summary

Filters